ASSOCIATION BETWEEN CYP2C9 PROMOTER REGION VARIANTS AND WARFARIN DOSE REQUIREMENTS IN AFRICAN AMERICANS.

被引：0
|
作者：
Cavallari, L. [1 ]
Drozda, K. [1 ]
Perera, M. [2 ]
Patel, S. [1 ]
Shapiro, N. [1 ]
Nutescu, E. [1 ]
Stamos, T. [1 ]
机构：
[1] Univ Illinois, Chicago, IL USA
[2] Univ Chicago, Chicago, IL 60637 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2011年 / 89卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S77 / S78
页数：2
相关论文
共 50 条
  • [1] Association between CYP2C9 polymorphism and warfarin dose
    Samardzija, M.
    Topic, E.
    Stefanovic, M.
    Zibar, L.
    Samardzija, G.
    Balen, S.
    Vcev, A.
    Domanovic, D.
    Barbic, J.
    Petrak, D.
    Sisljagic, V.
    BLOOD REVIEWS, 2007, 21 : S69 - S69
  • [2] CYP2C9 polymorphism and warfarin dose requirements
    Daly, AK
    Day, CP
    Aithal, GP
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (04) : 408 - 409
  • [3] Influence of CYP2C9 genotype on warfarin dose among African-Americans and European-Americans
    Limdi, Nita A.
    Goldstein, J. A.
    Blaisdell, J. A.
    Beasley, T. M.
    Rivers, C. A.
    Acton, R. T.
    PERSONALIZED MEDICINE, 2007, 4 (02) : 157 - 169
  • [4] VKORC1, APOE, CYP2C9 variants and their influences on warfarin dosing in African Americans
    Schelleman, H.
    Chen, Z.
    Kealey, C.
    Whitehead, A. S.
    Christie, J.
    Price, M.
    Brensinger, C. M.
    Newcomb, C. W.
    Thorn, C. F.
    Samaha, F. F.
    Kimmel, S. E.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S25 - S26
  • [5] Warfarin dose requirements in a patient with the CYP2C9*14 allele
    Lee, Yee Ming
    Eggen, Jessica
    Soni, Vinay
    Drozda, Katarzyna
    Nutescu, Edith A.
    Cavallari, Larisa H.
    PHARMACOGENOMICS, 2014, 15 (07) : 909 - 914
  • [6] Novel CYP2C9 polymorphisms and their relationship to warfarin dose requirements
    King, BP
    Khan, T
    Kamali, F
    Daly, AK
    DRUG METABOLISM REVIEWS, 2003, 35 : 133 - 133
  • [7] CYP2C9 Polymorphisms are associated with warfarin anticoagulation-dose requirements
    潘耀东
    李胜军
    河南外科学杂志, 2011, (06) : 1 - 2
  • [8] Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients
    Taisei Mushiroda
    Yozo Ohnishi
    Susumu Saito
    Atsushi Takahashi
    Yuka Kikuchi
    Shigeru Saito
    Hideki Shimomura
    Yasuhiko Wanibuchi
    Takao Suzuki
    Naoyuki Kamatani
    Yusuke Nakamura
    Journal of Human Genetics, 2006, 51 : 249 - 253
  • [9] Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients
    Mushiroda, T
    Ohnishi, Y
    Saito, S
    Takahashi, A
    Kikuchi, Y
    Saito, S
    Shimomura, H
    Wanibuchi, Y
    Suzuki, T
    Kamatani, N
    Nakamura, Y
    JOURNAL OF HUMAN GENETICS, 2006, 51 (03) : 249 - 253
  • [10] A study on the relationship between warfarin dose and CYP2C9 polymorphism
    Yeneka, LA
    Hung, A
    Gaffney, D
    CLINICA CHIMICA ACTA, 2005, 355 : S388 - S388
12345